During the past decade, Onkologisches Zentrum Lebach conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Onkologisches Zentrum Lebach" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "German CLL Study Group" with 2 trials sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "The Lymphoma Academic Research Organisation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologisches Zentrum Lebach" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Israeli CLL Study Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Onkologisches Zentrum Lebach" are "Colorectal Cancer" (2 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Chronic Lymphoid Leukemia" (1 trials). Many other conditions were trialed in "Onkologisches Zentrum Lebach" in a lesser frequency.

Most popular intervention types in "Onkologisches Zentrum Lebach" are "Drug" (9 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Bendamustine" (2 trials), "Obinutuzumab" (2 trials), "Rituximab" (2 trials) and "Venetoclax" (2 trials). Other intervention names were less common.

The vast majority of trials in "Onkologisches Zentrum Lebach" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Onkologisches Zentrum Lebach". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Onkologisches Zentrum Lebach, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Onkologisches Zentrum Lebach, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".